Numerous studies investigating disturbances in glycinergic inhibition rely on mutations within the receptor genes GLRA1 and GLRB which have been associated with startle disease (hyperekplexia) derogating the nerve-muscle circuit (Schaefer et al., 2012; Chung et al., 2013). This evidence concerns the gene GLRA1 and hyperekplexia.